This inventor holds 1 USPTO granted patent. Top assignee: Laboratorios Dalmer Sa. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Abilo Laguna Granja: Innovator in Fatty Acid Mixtures
Introduction
Abilo Laguna Granja is a notable inventor based in Habana, Cuba. He has made significant contributions to the field of pharmaceutical formulations through his innovative work with fatty acids derived from sugar cane wax. His research focuses on the development of natural mixtures that possess unique pharmacological properties.
Latest Patents
Abilo Laguna Granja holds a patent for a "Mixture of primary fatty acids obtained from sugar cane wax." This invention features a new natural mixture of primary fatty acids with high molecular weights, specifically those ranging from 24 to 38 carbon atoms. The mixture is particularly effective with fatty acids that have straight chains of 26 to 36 carbon atoms. The relative composition of each fatty acid in this mixture is highly reproducible from batch to batch, making it a reliable component for various applications.
Career Highlights
Granja's work has led to the identification of specific pharmacological properties of these fatty acids. His invention supports its use as an active component in pharmaceutical formulations aimed at treating conditions such as hypercholesterolemia type II. Additionally, the mixture has shown effectiveness in inhibiting the development of gastric ulcers induced by various agents.
Collaborations
Throughout his career, Abilo has collaborated with notable colleagues, including Luis Gonzáles Bravo and David Marrero Delange. Their combined expertise has contributed to the advancement of research in this area.
Conclusion
Abilo Laguna Granja's innovative work in the field of fatty acids has the potential to significantly impact pharmaceutical formulations. His contributions highlight the importance of natural compounds in medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile